Fink, E. C., McConkey, M., Adams, D. N., Haldar, S. D., Kennedy, J. A., Guirguis, A. A., . . . Ebert, B. L. (2018). Crbn(I391V) is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice. Blood.
Citação norma ChicagoFink, Emma C., et al. "Crbn(I391V) Is Sufficient to Confer in Vivo Sensitivity to Thalidomide and Its Derivatives in Mice." Blood 2018.
Citação norma MLAFink, Emma C., et al. "Crbn(I391V) Is Sufficient to Confer in Vivo Sensitivity to Thalidomide and Its Derivatives in Mice." Blood 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.